Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

15.06.07	Drei Studien legen nah, dass Abbotts HUMIRA(R) (Adalimumab) möglicherweise die arbeitsbezogene Leistungsfähigkeit von Patienten mit rheumatoider Arthritis verbessert (PR Newswire)
15.06.07	Three Studies Suggest Abbott's HUMIRA(R) (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis (PR Newswire)
07.06.07	Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease (PR Newswire)
22.05.07	Neue Datenauswertung zeigt, dass die Behandlung mit Abbotts HUMIRA(R) (Adalimumab) krankheitsbedingte Krankenhauseinweisungen von Morbus Crohn Patienten signifikant verringert (PR Newswire)
30.04.07	Abbott Named Among the 'Top 10' on The Dave Thomas Foundation's '100 Best Adoption-Friendly Workplaces' List (PR Newswire)
27.02.07	HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease (PR Newswire)
08.01.07	Abbott m2000(TM) Molecular Diagnostic Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada (PR Newswire)
04.12.06	Abbott Introduces CE-Marked DNA Tests in Europe for the Detection of Chromosomal Abnormalities Associated With Leukemia (PR Newswire)
02.11.06	Abbott Fund, Baylor College of Medicine and the First Lady of Malawi Open the First Clinic for HIV-Infected Children in Malawi (PR Newswire)
02.11.06	Abbott Fund, Baylor College of Medicine and the First Lady of Malawi Open the First Clinic for HIV-Infected Children in Malawi (PR Newswire)
26.10.06	Abbott's HUMIRA(R) (Adalimumab) Granted FDA Priority Review for the Treatment of Moderately to Severely Active Crohn's Disease (PR Newswire)
11.10.06	Abbott Awards Virginia Mother $130,000 in National Similac(R) Contest (PR Newswire)
19.07.06	Abbott Announces Strong Second-Quarter Results and Raises Full-Year Earnings Outlook (PR Newswire)
05.07.06	Abbott and AstraZeneca Announce Collaboration to Develop and Commercialize CRESTOR(R) and Next-Generation TriCor(R) (ABT-335) Fixed-Dose Combination (PR Newswire)
05.07.06	Abbott and AstraZeneca Announce Collaboration to Develop and Commercialize CRESTOR(R) and Next-Generation TriCor(R) (ABT-335) Fixed-Dose Combination (PR Newswire)
03.07.06	Neue Tabletten-Darreichungsform von Abbotts Kaletra(R) (Lopinavir/Ritonavir) in Europa zugelassen (PR Newswire)
03.07.06	Abbott's New Tablet Formulation of Kaletra(R) (lopinavir/ritonavir) Approved in Europe (PR Newswire)
26.06.06	Abbott Receives FDA Approval for New HUMIRA(R) Delivery Device (PR Newswire)
26.06.06	Abbott Receives FDA Approval for New HUMIRA(R) Delivery Device (PR Newswire)
23.06.06	Jüngste Phase-III-Daten beweisen, dass Abbotts HUMIRA(R) (Adalimumab) die Reduzierung der Anzeichen und Symptome von ankylosierender Spondylitis über den Zeitraum von einem Jahr aufrechterhält (PR Newswire)
07.06.06	HUMIRA(R) (Adalimumab) von Abbott erhält Zulassung in der Europäischen Union für die Behandlung der schweren ankylosierenden Spondylitis (Morbus Bechterew) (PR Newswire)
22.05.06	Promising Pivotal Phase III Data Show Abbott's Humira(R) (Adalimumab) Maintained Clinical Remission in Patients With Crohn's Disease Through One Year (PR Newswire)
28.04.06	HUMIRA(R) (Adalimumab) von Abbott erhält positiven Bericht von der Europäischen Arzneimittelagentur zur Behandlung von ankylosierender Spondylitis (PR Newswire)
31.03.06	Abbott and Morgan Stanley Welcome the 14th Annual International Biotechnology Convention to Chicago for Its Midwestern Debut (PR Newswire)
13.03.06	Seven Summits Research Releases Comments on PFE, CVX, VOD, ABT, and WM (PR Newswire)
25.01.06	Abbott Reports Record Sales, Earnings and Cash Flow in 2005 (PR Newswire)
23.12.05	Medialink: 'Tis the Season for a Doctor's Visit? (Businesswire)
16.11.05	Abbott Reports Levosimendan (Simdax(R)) Results From Large Mortality Trial in Patients With Acute Decompensated Heart Failure (PR Newswire)
14.11.05	Abbott Reports Improved Clinical Course With Levosimendan (Simdax(R)) When Added to Standard Therapy in Acute Decompensated Heart Failure Trial (PR Newswire)
04.10.05	HUMIRA(R) (adalimumab) Receives FDA Approval for First-Line Treatment of Moderate to Severe Rheumatoid Arthritis (PR Newswire)
26.08.05	Abbott Makes FORTUNE's List of the Best Companies for Minorities for Eighth Consecutive Year (PR Newswire)
17.08.05	Abbott Statement Regarding U.S. Food and Drug Administration's Denial of Public Citizen's Petition Against Meridia(R) (sibutramine HCL monohydrate) Capsules C-IV (PR Newswire)
15.08.05	HUMIRA(R) (Adalimumab) Approved in Europe for the Treatment of Psoriatic Arthritis and as a First-Line Treatment of Severe Rheumatoid Arthritis (PR Newswire)
26.07.05	Clinicians Stress the Importance of Tests for Reproductive Health and Thyroid Disorders During 'Trends in Women's Health Workshop' (PR Newswire)
25.07.05	Abbott Announces U.S. 510(k) Clearance of CELL-DYN Sapphire(TM) Hematology Instrument (PR Newswire)
13.07.05	Abbott Reports 17.5 Percent Sales Increase in the Second Quarter (PR Newswire)
02.06.05	Advanced Medical Optics Announces Analyst Day Event and Live Webcast; Event to be Held June 9 in New York City (PR Newswire)
27.05.05	Abbott Announces FDA Approval of Zemplar(R) (paricalcitol) Capsules for Earlier Treatment of Kidney Disease Complication (PR Newswire)
25.05.05	Abbott Launches TriMaxx(TM) Coronary Stent and Five New Products for Vascular Intervention at Paris Course on Revascularization (PR Newswire)
16.05.05	New Phase III Data Shows Nearly Four Out Of Five Crohn's Patients Responded To Treatment With Abbott's HUMIRA(R) (Adalimumab) (PR Newswire)
28.04.05	Advanced Medical Optics Announces First-Quarter 2005 Results (PR Newswire)
25.04.05	Advanced Medical Optics and VISX Select Special Meeting Date for Propo (PR Newswire)
14.04.05	Abbott Fund and Baylor College of Medicine Partner to Create the First (PR Newswire)
08.04.05	Advanced Medical Optics and VISX Set Record Date for Voting on Propose (PR Newswire)
07.04.05	Abbott Receives FDA Approval to Begin ZOMAXX II U.S. Drug-Eluting Coro (PR Newswire)
02.03.05	Abbott Enters Into Agreement With Inpeco to Expand Laboratory Automati (PR Newswire)
16.02.05	Advanced Medical Optics, Inc. and VISX, Incorporated Update Timeline o (PR Newswire)
31.01.05	Newly Published Study Evaluates Abbott's HUMIRA(R) in Crohn's Disease (PR Newswire)
18.01.05	Abbott Reports 15.5 Percent Sales Increase in the Fourth Quarter; 13.9 (PR Newswire)
18.01.05	Abbott Announces Groundbreaking New Trial in Stroke Prevention (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Börse New York in Grün: So steht der NASDAQ 100 aktuell
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		SPI-Handel aktuell: SPI zum Handelsende leichter
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Börse New York in Grün: So steht der NASDAQ 100 aktuell

20.12.24

Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten